Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

38.57USD
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
$38.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
204,807
52-wk High
$73.90
52-wk Low
$22.23

About

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct... (more)

Overall

Beta: --
Market Cap(Mil.): $2,016.41
Shares Outstanding(Mil.): 52.28
Dividend: --
Yield (%): --

Financials

  CRSP.OQ Industry Sector
P/E (TTM): -- 110.36 63.23
EPS (TTM): -3.43 -- --
ROI: -45.95 7.96 11.76
ROE: -56.89 8.13 12.60

BRIEF-Crispr Therapeutics And Vertex Announce FDA Fast Track Designation For CTX001 For Treatment Of Beta Thalassemia

* CRISPR THERAPEUTICS AND VERTEX ANNOUNCE FDA FAST TRACK DESIGNATION FOR CTX001 FOR THE TREATMENT OF BETA THALASSEMIA Source text for Eikon: Further company coverage:

16 Apr 2019

Earnings vs. Estimates